362706-25-0 Usage
Uses
Used in Organic Chemistry:
1-BOC-5-Methyl-3-pyrrolidinone is used as a reagent for chemical synthesis, particularly in the field of organic chemistry, due to its high reactivity and versatility. It enables a broad range of reactions and processes, contributing to the development and production of various organic compounds.
Used in Pharmaceutical Industry:
1-BOC-5-Methyl-3-pyrrolidinone is used as an intermediate in the synthesis of pharmaceutical compounds for its ability to facilitate the formation of complex organic molecules, which are essential in the creation of new drugs and therapeutic agents.
Used in Research and Development:
In the research and development sector, 1-BOC-5-Methyl-3-pyrrolidinone is utilized as a key component in the exploration of new chemical reactions and the synthesis of novel organic compounds, driving innovation and advancement in the field of chemistry.
Used in Material Science:
1-BOC-5-Methyl-3-pyrrolidinone is employed in the synthesis of advanced materials, such as polymers and other specialty materials, leveraging its reactivity and versatility to create new materials with unique properties for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 362706-25-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,2,7,0 and 6 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 362706-25:
(8*3)+(7*6)+(6*2)+(5*7)+(4*0)+(3*6)+(2*2)+(1*5)=140
140 % 10 = 0
So 362706-25-0 is a valid CAS Registry Number.
362706-25-0Relevant articles and documents
DIHYDROPYRROLIDINO-PYRIMIDINES AS KINASE INHIBITORS
-
Page/Page column 84, (2014/04/04)
The present invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof; as further described herein. The present invention further provides pharmaceutical compositions comprising these compounds, and combinations comprising these compounds combined with or used with a therapeutic co-agent, as well as therapeutic uses of these compounds and compositions. These are useful in the treatment of diseases such as cancer that are associated with activation of ERKl and/or ERK2, and especially for MAPK pathway dependent cancers showing resistance to Raf and/or MEK inhibitory cancer therapeutics
BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS
-
Page/Page column 24-25, (2010/12/29)
The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1 ), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and diabetes.
Beta-Amino-Acid derivatives as inhibitors of matrix metalloproteases and TNF-Alpha
-
, (2008/06/13)
The present application describes novel β-amino acid derivatives of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, Ua, Xa, Ya, Za, R1, R2, R3, R4, and R4a are defined in the present specification, which are useful as metalloprotease and/or as TNF-α inhibitors.